5-epi-Isofagomine structure
|
Common Name | 5-epi-Isofagomine | ||
|---|---|---|---|---|
| CAS Number | 169105-89-9 | Molecular Weight | 147.17 | |
| Density | 1.3±0.1 g/cm3 | Boiling Point | 317.2±37.0 °C at 760 mmHg | |
| Molecular Formula | C6H13NO3 | Melting Point | N/A | |
| MSDS | N/A | Flash Point | 171.8±17.1 °C | |
Use of 5-epi-IsofagomineAfegostat was previously in phase II clinical trials for the treatment of Gaucher's disease. The experiment was discontinued. |
| Name | (3R,4R,5R)-5-(hydroxymethyl)piperidine-3,4-diol |
|---|---|
| Synonym | More Synonyms |
| Description | Afegostat was previously in phase II clinical trials for the treatment of Gaucher's disease. The experiment was discontinued. |
|---|---|
| Related Catalog | |
| References |
| Density | 1.3±0.1 g/cm3 |
|---|---|
| Boiling Point | 317.2±37.0 °C at 760 mmHg |
| Molecular Formula | C6H13NO3 |
| Molecular Weight | 147.17 |
| Flash Point | 171.8±17.1 °C |
| PSA | 72.72000 |
| LogP | -1.80 |
| Vapour Pressure | 0.0±1.5 mmHg at 25°C |
| Index of Refraction | 1.535 |
| InChIKey | QPYJXFZUIJOGNX-HSUXUTPPSA-N |
| SMILES | OCC1CNCC(O)C1O |
| IFM |
| 5-HYDROXYMETHYL-3,4-DIHYDROXYPIPERIDINE |
| (3R,4R,5S)-5-(Hydroxymethyl)piperidine-3,4-diol |
| 5-epi-Isofagomine |
| iso-Fagomine |
| (3R,4R,5S)-5-(Hydroxymethyl)-3,4-piperidinediol |
| 1oif |
| D-Isofagomine |
| Afegostat |